These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. [How hypervigilance and hyperreactivity clinically described in anxiety expressed physiologically?]. Zullino D; Khazaal Y; Hättenschwiler J; Borgeat F Sante Ment Que; 2004; 29(1):23-32. PubMed ID: 15470559 [TBL] [Abstract][Full Text] [Related]
49. A pragmatic randomized controlled trial of group transdiagnostic cognitive-behaviour therapy for anxiety disorders in primary care: study protocol. Roberge P; Provencher MD; Gosselin P; Vasiliadis HM; Gaboury I; Benoit A; Antony MM; Chaillet N; Houle J; Hudon C; Norton PJ BMC Psychiatry; 2018 Oct; 18(1):320. PubMed ID: 30285672 [TBL] [Abstract][Full Text] [Related]
50. [Practice guidelines--therapy of anxiety and compulsive disorders. Recommendations for therapy of anxiety and compulsive disorders of the Drug Commission of the German Medical Society]. Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):241-4. PubMed ID: 10802900 [No Abstract] [Full Text] [Related]
51. [Current and emerging features of obsessive-compulsive disorder--trends for the revision of DSM-5]. Matsunaga H Seishin Shinkeigaku Zasshi; 2012; 114(9):1023-30. PubMed ID: 23198591 [TBL] [Abstract][Full Text] [Related]
52. Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. Ninan PT; Rush AJ; Crits-Christoph P; Kornstein SG; Manber R; Thase ME; Trivedi MH; Rothbaum BO; Zajecka J; Borian FE; Keller MB J Clin Psychiatry; 2002 May; 63(5):434-41. PubMed ID: 12025827 [TBL] [Abstract][Full Text] [Related]
53. Affective styles in mood and anxiety disorders - Clinical validation of the "Affective Style Questionnaire" (ASQ). Totzeck C; Teismann T; Hofmann SG; von Brachel R; Zhang XC; Pflug V; Margraf J J Affect Disord; 2018 Oct; 238():392-398. PubMed ID: 29909302 [TBL] [Abstract][Full Text] [Related]
55. [The role of inhibition in obsessional-compulsive disorders]. Dupuy M; Rouillon F; Bungener C Encephale; 2013 Feb; 39(1):44-50. PubMed ID: 23095598 [TBL] [Abstract][Full Text] [Related]
56. The structure and intensity of self-reported autonomic arousal symptoms across anxiety disorders and obsessive-compulsive disorder. Berle D; Starcevic V; Milicevic D; Hannan A; Dale E; Skepper B; Viswasam K; Brakoulias V J Affect Disord; 2016 Jul; 199():81-6. PubMed ID: 27093491 [TBL] [Abstract][Full Text] [Related]
57. A cognitive behavioral case formulation framework for treatment planning in anxiety disorders. Boschen MJ; Oei TP Depress Anxiety; 2008; 25(10):811-23. PubMed ID: 17385728 [TBL] [Abstract][Full Text] [Related]